Deep Brain Stimulation in Neurological and Psychiatric Disorders

Deutsches Ärzteblatt International
Volker A CoenenT E Schläpfer

Abstract

Deep brain stimulation (DBS) is the chronic electrical stimulation of selected target sites in the brain through stereotactically implanted electrodes. More than 150 000 patients around the world have been treated to date with DBS for medically intractable conditions. The indications for DBS include movement disorders, epilepsy, and some types of mental illness. This review is based on relevant publications retrieved by a selective search in PubMed and the Cochrane Library, and on the current guidelines of the German Neurological Society (Deutsche Gesellschaft für Neurologie, DGN). DBS is usually performed to treat neurological diseases, most often movement disorders and, in particular, Parkinson's disease. Multiple randomized controlled trials (RCTs) have shown that DBS improves tremor, dyskinesia, and quality of life in patients with Parkinson's disease by 25% to 50%, depending on the rating scales used. DBS for tremor usually involves stimulation in the cerebello-thalamo-cortical regulatory loop. In an RCT of DBS for the treatment of primary generalized dystonia, the patients who underwent DBS experienced a 39.3% improvement of dystonia, compared to only 4.9% in the control group. Two multicenter trials of DBS for depression...Continue Reading

References

Feb 17, 2000·The New England Journal of Medicine·P R SchuurmanJ D Speelman
Jun 13, 2002·Epilepsia·Mojgan HodaieAndres M Lozano
Oct 23, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·O SydowJ D Speelman
Feb 4, 2005·The New England Journal of Medicine·Marie VidailhetUNKNOWN French Stimulation du Pallidum Interne dans la Dystonie (SPIDY) Study Group
Mar 8, 2005·Neuron·Helen S MaybergSidney H Kennedy
Apr 13, 2005·Archives of Neurology·Valerie C AndersonJohn P Hammerstad
Sep 1, 2006·The New England Journal of Medicine·Günther DeuschlUNKNOWN German Parkinson Study Group, Neurostimulation Section
Nov 10, 2006·The New England Journal of Medicine·Andreas KupschUNKNOWN Deep-Brain Stimulation for Dystonia Study Group
Apr 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas E SchlaepferVolker Sturm
Apr 19, 2007·Brain : a Journal of Neurology·Jan HerzogJens Volkmann
Oct 2, 2007·Brain : a Journal of Neurology·Zelma H T KissUNKNOWN Canadian Movement Disorders Group
Oct 9, 2007·British Journal of Neurosurgery·P BlomstedtL-O D Koskinen
Aug 2, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Jorge GuridiJose A Obeso
Sep 2, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Alberto J EspayFredy J Revilla
Oct 10, 2008·Biological Psychiatry·Donald A MaloneBenjamin D Greenberg
Mar 10, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Elena MoroAnthony E Lang
Mar 12, 2010·Deutsches Ärzteblatt International·Jens KuhnWolfgang Huff
Jun 4, 2010·The New England Journal of Medicine·Kenneth A FollettUNKNOWN CSP 468 Study Group
Aug 4, 2010·Nature Reviews. Neurology·Jens VolkmannKarsten Witt
Aug 24, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·H C F MartensJerrold L Vitek
Oct 15, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel WeissAlireza Gharabaghi
Sep 20, 2011·Parkinsonism & Related Disorders·Amy W AmaraHarrison C Walker
Nov 29, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I M SkogseidG K Røste
Dec 30, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·Anders FytagoridisPatric Blomstedt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.